Overview

Kelly Murphy focuses his practice on counseling clients on intellectual property matters and U.S. government contracts and procurement regulations.

  • Advises clients on patent procurement, regulatory compliance, and negotiation of licensing, collaboration, and service agreements for pharmaceutical and technology companies, food and ingredient manufacturers, nonprofits, and academic institutions
  • Assists clients in procuring and enforcing domestic and international patents; conducting due diligence; and rendering legal opinions on patent validity or non-infringement

Services

Industries

Experience

Representative Matters

  • Represented pharmaceutical and technology companies with implementing life cycle strategies for approved therapeutics and marketed products, including
    • Procured domestic and international patents
    • Defended against filed oppositions and inter partes reexamination
    • Obtained national patent listings
    • Filed applications for supplemental protection certificates and patent term extensions
    • Negotiated exclusive license agreements, cooperative research and development agreements, and clinical trial agreements 
  • Represented multinational food manufacturer with patent procurement and patent clearances for global launches of new products and reformulations
  • Prosecuted and obtained numerous patents, including:
    • U.S. Patent No. 8,367,628 Amphoteric Liposome Formulations
    • U.S. Patent No. 7,960,544 Useful Indole Compounds
    • U.S. Patent No. 7,807,647 Methods and Compositions for Cancer Therapy
    • U.S. Patent Nos. 7,704,947; 7,772,188; 7,745,409; 7,910,546 8,080,526; 8,101,579; 8,110,553 Methods and Compositions for the Treatment of Gastrointestinal Disorders
    • U.S. Patent No. 7,659,088: Assay for Inositol Phosphorylceramide Synthase Activity
    • U.S. Patent No. 7,498,315: Methods and Compositions for the Inhibition of Gene Expression
    • U.S. Patent No. D595422: Support device for interventional instruments
    • U.S. Patent No. 7,524,827: Methods and Compositions for the Inhibition of Gene Expression
    • U.S. Patent No. D570,532: Light Fixture Lens and Bezel
    • U.S. Patent No. 7,322,722 B2: Light Fixture
    • U.S. Patent No. 7,374,319: Lighted Handle 

Prior Experience

  • Miller, Canfield, Paddock and Stone, P.L.C., Associate, 2007-2008
  • National Institute of Allergy and Infectious Diseases, National Institutes of Health, 2005-2007
  • Human Genome Sciences, 2001-2004
  • Invitrogen Corporation, 2000-2001

Credentials

Education

Admissions

Recognition

Awards

LMG Life Sciences 

  • Patent Prosecution Attorney of the Year – 2021 – Shortlisted nominee
  • Recognized as a Life Sciences Star, 2020, 2021
  • Recognized for Patent Prosecution

2015 Client Choice Award by the International Law Office

Michigan Super Lawyers, Recognized as a Rising Star, 2009-2014

Professional & Community Involvement

American Bar Association

  • Intellectual Property Law Section 

American Intellectual Property Law Association 

State Bar of Michigan

  • Intellectual Property Law Section 

District of Columbia Bar Association

  • Intellectual Property Law Section 

American Association for the Advancement of Science 

Kalamazoo County Bar Association 

Biotechnology Industry Organization 

MichBio

Gilmore Keyboard Festival

  • Board of Trustees, 2014-present

Crescendo Academy of Music

  • Board of Directors, 2010-2012

News & Insights

News

  • Kelly T. Murphy quoted in MiBiz article “Experts: Timing perfect for investment in life science startups”
    Media |

Publications

  • The Changing Tide of Patentability Standards and Filing Timelines for Biotechnologies
    Publication | The Impact of Recent Patent Law Cases and Developments, Aspatore: Inside the Minds™ | 2012
  • Lifting the R&D Organizational Veil under the American Recovery Reinvestment Act
    Publication | Michigan Biosciences LINK |
  • Development of a Long-acting Insulin Analog Using Albumin Fusion Technology
    Publication | 54 (1) Diabetes 251-258 |
  • Use of Fluorescently Labeled DNA and a Scanner for Electrophoretic Mobility Shift Assays
    Publication | 30(s) Biotechniques 504-506 |
  • The Role of NF-kB in Breast Carcinoma and Glioblastoma Cell Lines
    Publication | Thesis Publication, Dwight B. Waldo Library, General Stacks, Western Michigan University, Department of Biological Sciences |

Seminars & Events

  • Demystifying Government Use Rights: What Funding Recipients Should Know
    Event | San Antonio, TX | February 28-March 2, 2013 | | Moderator and presenter
  • Tech Transfer and Co-Development Partnerships with the NIH
    Event | East Lansing, MI | November 7-8, 2012 | | Moderator
  • America Invents Act Comes to Campus: The Impact on Commercialization and Technology Transfer Offices
    Event | Boston, MA | June 18-21, 2012 | Moderator
  • Emerging Business: Protecting IP – Patent Reform, PTO Changes & Court Decisions
    Event | Grand Rapids, MI | | | Co-presenter
  • Impact of U.S. Patent Reform on Biotechnology
    Event | Grand Rapids, MI | | Presenter
  • Understanding the Other Side of the Table: Perspectives from commercial licensees
    Event | Rockville, MD |
  • IP Protocol for the Central Corridor Licensing Partnership
    Event | Detroit, MI | |
  • Technology Development for Extramural Programs, Division of Acquired Immunodeficiency Syndrome
    Event | Bethesda, MD | |
  • NIAID’s Technology Transfer and Intellectual Property Resources
    Event | Bethesda, MD | |
  • Inhibition of NF-kB Reduces Cellular Proliferation and Foci Formation in Breast Carcinomas and Glioblastomas
    Event | Washington, D.C. | December 11-15, 1999 |
Jump to Page

By using this site, you agree to our Privacy Policy and our Disclaimer.